Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53

Oncogene volume 19, pages 3395–3403 (2000)Cite this article

Abstract

It is now well accepted that the p53 C-terminus plays a central role in controlling the activity of the wild-type molecule. In our previous studies, we observed that a C-terminally altered p53 protein (p53AS), generated by an alternative spliced p53 mRNA, induces an attenuated p53-dependent apoptosis, compared to that induced by the regularly spliced form (p53RS). In the present study we analysed the interrelationships between these two physiological variants of wild-type p53, and found that in cells co-expressing both forms, in contrast to the expected additive effect on the induction of apoptosis, p53AS inhibits apoptosis induced by p53RS. This inhibitory effect is specific for p53-dependent apoptosis and was not evident in a p53-independent apoptotic pathway induced by growth factor deprivation. Furthermore, the expression of p53AS in transiently transfected cells caused both inhibition of apoptosis and inhibition of the p53RS-dependent transactivation of a number of p53 target genes. These results suggest that expression of an alternatively spliced p53 form may serve as an additional level in controlling the complexity of p53 function by the C-terminal domain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Almog N, Li R, Peled A, Schwartz D, Wolkowicz R, Goldfinger N, Pei H and Rotter V. . 1997 Mol. Cell. Biol. 17: 713–722.

  • Almog N and Rotter V. . 1998 Biochim. Biophys. Acta 1378: R43–R54.

  • Arai N, Nomura D, Yokota K, Wolf D, Brill E, Shohat O and Rotter V. . 1986 Mol. Cell. Biol. 6: 3232–3239.

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. . 1993 Nature 362: 849–852.

  • De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M and Melino G. . 1998 J. Exp. Med. 188: 1763–1768.

  • Flaman J-M, Waridel F, Estreicher A, Vannier A, Limacher J-M, Gilbert D, Iggo R and Frebourg T. . 1996 Oncogene 12: 813–818.

  • Ford JM and Hanawalt PC. . 1997 J. Biol. Chem. 272: 28073–28080.

  • Foulkes N and Sassone-Corsi P. . 1992 Cell 68: 411–414.

  • Gannon JV, Greaves R, Iggo R and Lane DP. . 1990 EMBO J. 9: 1595–1602.

  • Giaccia AJ and Kastan MB. . 1998 Genes Dev. 12: 2973–2983.

  • Gottlieb TM and Oren M. . 1996 Biochim. Biophys. Acta 1287: 77–102.

  • Gu W and Roeder RG. . 1997 Cell 90: 595–606.

  • Hall PA and Lane DP. . 1997 Curr. Biol. 7: R144–R147.

  • Han K and Kulesz-Martin MF. . 1992 Nucleic Acids Res. 20: 1979–1981.

  • Harlow E, Crawford LV, Pim DC and Williamson NM. . 1981 J. Virol. 39: 861–869.

  • Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. . 1995 Genes Dev. 9: 2170–2183.

  • Hupp TR, Meek DW, Midgley CA and Lane DP. . 1992 Cell 71: 875–886.

  • Hupp TR, Meek DW, Midgley CA and Lane DP. . 1993 Nucleic Acids Res. 21: 3167–3174.

  • Jayaraman L, Moorthy NC, Murthy KGK, Manley JL, Bustin M and Prives C. . 1998 Genes Dev. 12: 462–472.

  • Jayaraman L, Murthy KGK, Zhu C, Curran T, Xanthoudakis S and Prives C. . 1997 Genes Dev. 11: 558–570.

  • Jayaraman L and Prives C. . 1995 Cell 81: 1021–1029.

  • Jost CA, Marin MC and Kaelin Jr WG. . 1997 Nature 389: 191–194.

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1991 Cancer Res. 51: 6304–6311.

  • Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunket BS, Vogelstein B and Fornace AJ. . 1992 Cell 71: 587–597.

  • Ko JL and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Kubbutat MHG, Ludwig RL, Ashcroft M and Vousden KH. . 1998 Mol. Cell. Biol. 18: 5690–5698.

  • Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. . 1992 Proc. Natl. Acad. Sci. USA 89: 7491–7495.

  • Kulesz-Martin MF, Lisafeld B, Huang H, Kisiel ND and Lee L. . 1994 Mol. Cell. Biol. 14: 1698–1708.

  • Lane DP. . 1992 Nature 358: 15–16.

  • Lee S, Elenbaas B, Levine A and Griffith J. . 1995 Cell 81: 1013–1020.

  • Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. . 1992 Cell 70: 923–935.

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. . 1993 Nature 362: 847–853.

  • Lu X and Lane DP. . 1993 Cell 75: 765–778.

  • Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694.

  • McMasters KM, Montes de Oca Luna R, Pena JR and Lozano G. . 1996 Oncogene 13: 1731–1736.

  • Meek DW. . 1999 Oncogene 18: 7666–7675.

  • Miner Z and Kulesz-Martin M. . 1997 Nucleic Acids Res. 25: 1319–1326.

  • Morgenstern PJ and Land H. . 1990 Nucleic Acids Res. 18: 3587–3596.

  • Muller-Tiemann BF, Halazonetis TD and Elting JJ. . 1998 Proc. Natl. Acad. Sci. USA 26: 6079–6084.

  • Okorov AL, Ponchel F and Milner J. . 1997 EMBO J. 16: 6008–6017.

  • Oltvai ZN and Korsmeyer SJ. . 1994 Cell 79: 189–192.

  • Oren M. . 1994 Semin. Cancer Biol. 5: 221–227.

  • Osada M, Ohba M, Kawahara C, Ishioka C, Kanamura R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M and Ikawa S. . 1998 Nature Medicine 4: 839–843.

  • Peled A, Lee BC, Toledo J, Aracil M and Zipori D. . 1996a Exp. Hematol. 24: 728–737.

  • Peled A, Zipori D and Rotter V. . 1996b Cancer Res. 56: 2148–2156.

  • Reed M, Woelker B, Wang P, Wang Y, Anderson ME and Tegtmeyer P. . 1995 Proc. Natl. Acad. Sci. USA 92: 9455–9459.

  • Rehberger AP, Richter KH, Schwartz D, Goldfinger N, Oskato R, Almog N, Marks F and Rotter V. . 1997 Cell Growth Differ. 8: 851–860.

  • Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Simons A, Wolkowicz R, Lavigne M, Besserman P, Kapon A and Goldfinger N. . 1994 Semin. Cancer Biol. 5: 229–236.

  • Rowan S, Ludwig RL, Haput Y, Bates S, Lu X, Oren M and Vousden KH. . 1996 EMBO J. 15: 827–838.

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW and Appella E. . 1998 Genes Dev. 12: 2831–2841.

  • Schmale H and Bamberger C. . 1997 Oncogene 15: 1363–1367.

  • Selivanova G, Iotsova V, Okan I, Fritsche M, Strome M, Groner B, Graftstrom RC and Wiman KG. . 1997 Nat. Med. 3: 632–638.

  • Shaulian E, Haviv I, Shaul Y and Oren M. . 1995 Oncogene 10: 671–680.

  • Shaw P, Freeman J, Bovey R and Iggo R. . 1996 Oncogene 12: 921–930.

  • Steegenga TW, van der Eb JA and Jochemsen GA. . 1996 J. Mol. Biol. 263: 103–113.

  • Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and Van Dyke T. . 1994 Cell 78: 703–711.

  • Trink B, Okami K, Wu L, Sriuranpong V, Jen J and Sidransky D. . 1998 Nature Med. 4: 747–748.

  • Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C. . 1995 J. Immunol. Methods 184: 39–51.

  • Wang XW, Vermwulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JHJ and Harris CC. . 1996 Genes Dev. 10: 1219–1232.

  • Wang XW, Yeh H, Schaeffer L, Roy R, Moncolli V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC. . 1995 Nat. Genet. 10: 188–195.

  • Waterman MJF, Stavridi ES, Waterman JLF and Halazonetis TD. . 1998 Nat. Genet. 19: 175–178.

  • Will K, Warnecke G, Bergmann S and Deppert W. . 1995 Nucl. Acids Res. 23: 4023–4028.

  • Williams GT. . 1991 Cell 65: 1097–1098.

  • Wolf D, Harris N, Goldfinger N and Rotter V. . 1985 Mol. Cell. Biol. 5: 127–132.

  • Wolkowicz R, Peled A, Elkind NB and Rotter V. . 1995 Proc. Natl. Acad. Sci. USA 92: 6842–6846.

  • Wolkowicz R and Rotter V. . 1997 Pathol. Biol. (Paris) 45: 785–796.

  • Wu L, Bayle H, Elenbaas B, Pavletich NP and Levine AJ. . 1995 Mol. Cell Biol. 15: 497–504.

  • Wu Y, Huang H, Miner Z and Kulesz-Martin M. . 1997 Proc. Natl. Acad. Sci. USA 94: 8982–8987.

  • Wyllie AH. . 1995 Curr. Opin. Genet. Dev. 5: 97–104.

  • Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. . 1998 Mol. Cell 2: 305–316.

  • Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P and Oren M. . 1993 Mol. Cell. Biol. 13: 1415–1423.

  • Yonish-Rouach E, Resnitzky K, Loten J, Sachs L, Kimchi A and Oren M. . 1991 Nature 352: 345–347.

  • Zhou X, Wang XW, Xu L, Hagiwara K, Nagashima M, Wolkowicz R, Zurer I, Rotter V and Harris CC. . 1999 Cancer Res. 59: 843–848.

Download references

Acknowledgements

This study was supported by a grant from the Israel Cancer Association and in part by grants from the Israel-USA Binational Science Foundation, the German Israeli Foundation for Scientific Research and Development and the Israel Cancer Research Fund (V Rotter). V Rotter is the incumbent of the Norman and Helen Asher Professional Chair in Cancer Research at the Weizmann Institute.

Author information

Authors and Affiliations

  1. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel

    Nava Almog, Naomi Goldfinger & Varda Rotter

Authors
  1. Nava Almog
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naomi Goldfinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Varda Rotter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Almog, N., Goldfinger, N. & Rotter, V. p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53. Oncogene 19, 3395–3403 (2000). https://doi.org/10.1038/sj.onc.1203673

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203673

Keywords

This article is cited by

Search

Advanced search

Quick links